ロード中...

Myostatin Is a Quantifiable Biomarker for Monitoring Pharmaco-gene Therapy in Duchenne Muscular Dystrophy

Recently, several promising treatments have emerged for neuromuscular disorders, highlighting the need for robust biomarkers for monitoring therapeutic efficacy and maintenance of the therapeutic effect. Several studies have proposed circulating and tissue biomarkers, but none of them has been valid...

詳細記述

保存先:
書誌詳細
出版年:Mol Ther Methods Clin Dev
主要な著者: Mariot, Virginie, Le Guiner, Caroline, Barthélémy, Inès, Montus, Marie, Blot, Stéphane, Torelli, Silvia, Morgan, Jennifer, Muntoni, Francesco, Voit, Thomas, Dumonceaux, Julie
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Gene & Cell Therapy 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7363622/
https://ncbi.nlm.nih.gov/pubmed/32695843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2020.06.016
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!